研究業績
英文論文 2011年度
- Sakamoto, Y.，Kato, S.，Takahashi , M.，Okada, Y.，Yasuda, K.，Watabe, G.，Imai, H.，Sato, A.，Ishioka, C. Contribution of autphagic cell death to p53-dependent cell death in human glioblastoma cell line SF126. Cancer Sci Apr;102(4): 799-807 (2011)
- Kais, Z.，Chiba.N，Ishioka, C.，Parrvin, J. Functional differences among BRCA1 missense mutations in the control of centrosome duplication. Oncogene (2011)
- Sato, A.，Kudo, C.，Yamakoshi, H.，Uehara, Y.，Ohrui, H.，Ishioka, C.，Iwabuchi, Y.，Shibata, H. Curcumin analog GO-Y030 is a novel inhabitor of IKKβ that suppresses NF-kB signaling and induces apotosis. Cancer Sci. 105(2): 1045-51 (2011)
- Kudo, C.，Yamakoshi, H.，Sato, A.，Nanjyo, H.，Ohrui, H.，Ishioka, C.，Iwabuchi, Y.，Shibata, H. Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo. BMC Pharmacol. 11: 4 (2011)
- Takahashi, M., Koi, M., Balaguer, F., Boland, C.R., Goel, A. MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor. J Biol Chem. Apr 8;286(14):12157-65. (2011)
- Kudo, C.，Yamakoshi, H.，Sato, A.，Ohori, H.，Ishioka, C.，Iwabuchi, Y.，Shibata, H. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res (11):37: 19-26 (2011)
- Wei L，Lan L，Yasui A，Tanaka K，Saijo M，Matsuzawa A，Kashiwagi R，Maseki E，Hu Y，Parvin JD，Ishioka C，N., C. BRCA1 contributes to transcription-coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein. Cancer Sci. 102(10): 1840-7. (2011)
- Yoshida, K.，Nagai, T.，Ohmine, K.，Uesawa, M.，Sripayap, P.，Ishida, Y.，Ozawa, K. Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells. Biochem Pharmacol 82: 1884-90 (2011)